Skip to main content

Corporate insider profile

Brian M Culley Insider Trades

Brian M Culley has reported 1 open-market purchase on SEC Form 4 and is a net buyer of $37,098 across 1 company. The most recent open-market transaction was reported on Nov 16, 2026. Source: SEC Form 4 filings.

Latest reported as President and CEO of Lineage Cell Therapeutics, Inc. (LCTX).

SEC-reported filing activity is provided for research purposes and is not investment advice.

Purchase filings
1
Reported companies
1
Net open-market value
$37,098
Latest transaction
Nov 16, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Nov 16, 2026Lineage Cell Therapeutics, Inc. (LCTX)President and CEOOpen Market Purchase40,500$0.92$37,098

Common questions

Brian M Culley insider trading FAQ

Is Brian M Culley buying or selling stock?
Across all SEC Form 4 open-market filings on record, Brian M Culley is a net buyer of $37,098, with 1 open-market purchase reported. The latest transaction was reported on Nov 16, 2026.
Which companies does Brian M Culley report insider trades for?
Brian M Culley has reported open-market trades in Lineage Cell Therapeutics, Inc. (LCTX). The latest SEC-reported relationship is President and CEO of Lineage Cell Therapeutics, Inc. (LCTX).
Where does Brian M Culley's insider trading data come from?
Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1310683, and refreshes this page daily.